Literature DB >> 3803311

Effects of iopanoic acid on thyroid hormone receptor, growth hormone production, and triiodothyronine generation from thyroxine in pituitary GH1 cells.

A Pascual, F Montiel, A Aranda.   

Abstract

We have studied the effect of iopanoic acid (IOP), a radiographic contrast agent which inhibits T4 to T3 conversion, on thyroid hormone nuclear receptors, GH response to T4 and T3, and T4 5'-monodeiodination in GH1 cells, a rat pituitary cell line. IOP at concentrations higher than 10 microM inhibits iodothyronine binding to the nuclear receptor without changing the dissociation constant (Kd) (0.1 nM for T3 and 1 nM for T4), and reduces the GH response to 50 nM T4, 5 nM T3, or the combined effect of T4 and glucocorticoids. These results could be explained by an inhibition of protein synthesis which was reduced by more than 50% by 50 microM IOP. By contrast, nontoxic concentrations of IOP did not change the GH response to different doses of T4 ranging from 1 nM to 50 nM. We also examined T3 generation from T4 and found that the intracellular T3 levels of cells incubated with 50 nM T4 were almost as high as those of cells incubated with 5 nM T3 which induces a full GH response. Intracellular T3 levels were markedly reduced in the cells incubated with T4 and IOP, but GH production was not reduced despite these differences in T3 levels. Additionally, more than 40% of the nuclear receptor was occupied by T3 in cells incubated with T4, whereas more than 90% was occupied by T4 in cells receiving the same amount of T4 with 5 microM IOP. Our results suggest that the effect of T4 on GH production by GH1 cells could be attributed to an important extent to the T3 generated from it, whereas when T4 monodeiodination is strongly inhibited, most of the biological activity is a result of intrinsic T4 activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3803311     DOI: 10.1210/endo-120-3-1089

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats.

Authors:  H F Escobar-Morreale; M J Obregón; F Escobar del Rey; G Morreale de Escobar
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

2.  The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance.

Authors:  A C Hepburn; R E Steele; R Veeratterapillay; L Wilson; E E Kounatidou; A Barnard; P Berry; J R Cassidy; M Moad; A El-Sherif; L Gaughan; I G Mills; C N Robson; R Heer
Journal:  Oncogene       Date:  2019-02-11       Impact factor: 9.867

3.  Targeting iodothyronine deiodinases locally in the retina is a therapeutic strategy for retinal degeneration.

Authors:  Fan Yang; Hongwei Ma; Joshua Belcher; Michael R Butler; T Michael Redmond; Sanford L Boye; William W Hauswirth; Xi-Qin Ding
Journal:  FASEB J       Date:  2016-09-13       Impact factor: 5.191

4.  Sodium ipodate increases triiodothyronine action in vivo.

Authors:  J H Hays; C Eil; R C Smallridge
Journal:  J Endocrinol Invest       Date:  1992 Jul-Aug       Impact factor: 4.256

5.  Role of L-thyroxine in nuclear thyroid hormone receptor occupancy and growth hormone production in cultured GC cells.

Authors:  Y Halperin; L E Shapiro; M I Surks
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

Review 6.  Multifunctional receptor model for dioxin and related compound toxic action: possible thyroid hormone-responsive effector-linked site.

Authors:  J D McKinney
Journal:  Environ Health Perspect       Date:  1989-07       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.